Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Barron

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
JAMA Internal Medicine|June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in AdultsRyan E Wiegand, Amanda B Payne, Josephine Mak, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational StudyStephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
Vaccine|July 2, 2026
Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024Amber Kautz, Duck-Hye Yang, Sean Chickery, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine EffectivenessAlexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
JAMA Internal Medicine|June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in AdultsRyan E Wiegand, Amanda B Payne, Josephine Mak, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational StudyStephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
Vaccine|July 2, 2026
Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024Amber Kautz, Duck-Hye Yang, Sean Chickery, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine EffectivenessAlexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pageof 6